Functional MRI Study Reconstructed Breasts

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT03702556
Collaborator
(none)
30
1
3
22.6
1.3

Study Details

Study Description

Brief Summary

Rationale: To study the effects of mastectomy and autologous breast reconstruction on the sensation of the (reconstructed) breast, not only the peripheral reinnervation of the breast should be studied, but also the changes that take place in the somatosensory cortex. Now that the region of interest in the brain and the somatotopy of the non-operated breast are known, studies with patients who underwent mastectomy and breast reconstruction are the next step to understand the neuroplasticity of the brain following breast surgery.

Objective: To study the neuroplasticity of the brain after mastectomy and breast reconstructive surgery by assessing the somatotopy of the breast on the somatosensory cortex of patients who underwent either breast reconstruction with and without nerve restoration or mastectomy without breast reconstruction.

Study design: A single center imaging study carried out in Maastricht University Medical Center.

Study population: A total of 30 female breast cancer patients who underwent a unilateral mastectomy without breast reconstruction or a mastectomy followed by a unilateral autologous breast reconstruction with a deep inferior epigastric artery perforator (DIEP) flap will be included in this study. Three groups of patients will be selected and compared: ten patients who underwent a mastectomy without breast reconstruction, ten patients who underwent a DIEP flap breast reconstruction with sensory nerve restoration of the flap and ten patients who underwent a DIEP flap without nerve restoration.

Intervention: Every subject will undergo a single functional MRI scan in a 7 Tesla MRI scan at least six months after the operation. A scanning session takes approximately 75 minutes. During the scan, piezo-electric stimulators are applied to both the reconstructed and non-operated breast in a fixed pattern. These stimulators stimulate the skin and sensory nerves of the breast and nipple-areola complex in a random sequence.

Main study parameters: The hemodynamic response after stimulation of the skin of the breast and nipple-areola complex, representing neuronal activity in that region, is measured. Within the somatosensory cortex (S1 and S2), the temporo-spatial brain activity patterns after the various stimulation conditions are assessed, and the representation of the breast on the somatosensory cortex is mapped.

Condition or Disease Intervention/Treatment Phase
  • Device: MRI scan
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
The Representation of the Breast on the Somatosensory Cortex After Autologous Breast Reconstruction Using 7 Tesla Functional MRI.
Actual Study Start Date :
Feb 11, 2020
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mastectomy without breast reconstruction

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan
7.0 tesla functional MRI scan

Active Comparator: Breast reconstruction with nerve

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan
7.0 tesla functional MRI scan

Active Comparator: Breast reconstruction without nerve

Functional MRI scan of the somatosensory cortex while the breast skin is stimulated by piezo-stimulators.

Device: MRI scan
7.0 tesla functional MRI scan

Outcome Measures

Primary Outcome Measures

  1. The neuroplasticity of the brain after breast reconstruction [75 minutes]

    Changes in the blood oxygen level dependent (BOLD) contrast as a function of vibrotactile stimulation of the breast and nipple-areola complex will be measured. Changes will be analysed using multi-voxel pattern analysis to localize the different parts of the breast in the somatosensory cortex.

Secondary Outcome Measures

  1. Differences in the somatotopy between patients who underwent a breast reconstruction with nerve restoration compared to patients who underwent breast reconstruction without nerve restoration. [75 minutes]

    Differences between groups in somatotopy of the breast in the somatosensory cortex will be assessed.

  2. Differences in the somatotopy between patients who underwent mastectomy without breast reconstruction compared to patients who underwent breast reconstruction. [75 minutes]

    Differences between groups in somatotopy of the breast in the somatosensory cortex will be assessed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female over 18 years old

  • Unilateral mastectomy without breast reconstruction

  • Unilateral mastectomy with DIEP flap breast reconstruction (with or without sensory nerve restoration)

  • At least six months after the operation

  • Informed consent

Exclusion Criteria:
  • Bilateral mastectomy / breast reconstruction

  • Previous surgery, disease or treatment of the contralateral breast

  • Active disease / metastasis

  • Previous radiation therapy on the chest or axilla

  • Diseases associated with neuropathy (e.g. diabetes mellitus)

  • Previous brain surgery

  • Previous allergic reactions to adhesives or plasters

  • Any MRI exclusion criteria:

  • No piercings or other iron materials (except a metal brace behind front teeth)

  • Claustrophobia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maastricht University Medical Center Maastricht Limburg Netherlands 6229 HX

Sponsors and Collaborators

  • Maastricht University Medical Center

Investigators

  • Principal Investigator: RenĂ© Van der Hulst, MD, PhD, Maastricht University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT03702556
Other Study ID Numbers:
  • NL67696.068.18
First Posted:
Oct 11, 2018
Last Update Posted:
Feb 24, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 24, 2021